Mary Jo Fidler to Prostaglandins
This is a "connection" page, showing publications Mary Jo Fidler has written about Prostaglandins.
Connection Strength
0.131
-
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer. J Clin Oncol. 2015 Jan 10; 33(2):189-94.
Score: 0.131